tiprankstipranks
Trending News
More News >
Boundless Bio Inc. (BOLD)
NASDAQ:BOLD
US Market
Advertisement

Boundless Bio Inc. (BOLD) Stock Statistics & Valuation Metrics

Compare
31 Followers

Total Valuation

Boundless Bio Inc. has a market cap or net worth of $26.19M. The enterprise value is -$55.06M.
Market Cap$26.19M
Enterprise Value-$55.06M

Share Statistics

Boundless Bio Inc. has 22,385,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,385,610
Owned by Insiders8.20%
Owned by Institutions15.93%

Financial Efficiency

Boundless Bio Inc.’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -36.95%.
Return on Equity (ROE)-0.43
Return on Assets (ROA)-0.32
Return on Invested Capital (ROIC)-36.95%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee0.00
Profits Per Employee-1.02M
Employee Count64
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Boundless Bio Inc. is ―. Boundless Bio Inc.’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value0.33
Price to FCF
Price to Operating Cash Flow-0.47
PEG Ratio

Income Statement

In the last 12 months, Boundless Bio Inc. had revenue of 0.00 and earned -65.36M in profits. Earnings per share was -3.85.
Revenue0.00
Gross Profit-1.09M
Operating Income-73.27M
Pretax Income-65.36M
Net Income-65.36M
EBITDA-64.28M
Earnings Per Share (EPS)-3.85

Cash Flow

In the last 12 months, operating cash flow was -55.19M and capital expenditures -1.06M, giving a free cash flow of -56.24M billion.
Operating Cash Flow-55.19M
Free Cash Flow-56.24M
Free Cash Flow per Share-2.51

Dividends & Yields

Boundless Bio Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.89
52-Week Price Change-70.34%
50-Day Moving Average1.13
200-Day Moving Average1.81
Relative Strength Index (RSI)46.34
Average Volume (3m)89.84K

Important Dates

Boundless Bio Inc. upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).
Last Earnings DateAug 5, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date

Financial Position

Boundless Bio Inc. as a current ratio of 18.98, with Debt / Equity ratio of 40.35%
Current Ratio18.98
Quick Ratio18.98
Debt to Market Cap0.00
Net Debt to EBITDA-0.33
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Boundless Bio Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Boundless Bio Inc. EV to EBITDA ratio is -1.09, with an EV/FCF ratio of -1.11.
EV to Sales0.00
EV to EBITDA-1.09
EV to Free Cash Flow-1.11
EV to Operating Cash Flow-1.16

Balance Sheet

Boundless Bio Inc. has $127.15M in cash and marketable securities with $49.51M in debt, giving a net cash position of -$77.64M billion.
Cash & Marketable Securities$127.15M
Total Debt$49.51M
Net Cash-$77.64M
Net Cash Per Share-$3.47
Tangible Book Value Per Share$8.87

Margins

Gross margin is -4.83%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-4.83%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Boundless Bio Inc. is $3.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$3.50
Price Target Upside209.73% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast
EPS Growth Forecast-10.95%

Scores

Smart Score1
AI Score40
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis